About MSFrontier

MSFrontier brings together research on multiple sclerosis in one place: the clinical trials registered around the world and what they found, the reviews and guidelines that pool them, laboratory studies, and news from regulators and journals. From these it keeps an account of what is known about MS, what is still uncertain, and what is being tested now.

Most of the site is assembled by software from public sources and rebuilt every week. Software merges the trial registries, tags each trial, reads results, and judges each treatment idea by fixed rules that are published on the site. The course and the research overviews are written from published sources and cite them. None of it has yet been reviewed by an MS specialist, and we say so on every page.

MSFrontier is independent and free. It carries no advertising and takes no money from pharmaceutical companies. It is not medical advice: decisions about treatment belong with your MS team.